Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyFeng Zheng and Xiaoyang Yang of Wanhuida outline the various defence mechanisms patentees have at their disposal when facing infringement accusations in China -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law finds encouragement for developers of new chemical entity drugs after the rulings handed down in a battle between AstraZeneca and several generic pharmaceutical companies
-
Sponsored by Tilleke & GibbinsForeign investment in Myanmar is expected to receive a boost as a result of changes to the country’s trademark application process, report Khin Myo Myo Aye and Khin Yadanar Htay of Tilleke & Gibbins
-
Sponsored by Tilleke & GibbinsLinh Thi Mai Nguyen of Tilleke & Gibbins explains why an increase in trademark agents and intellectual property representation service organisations can be expected because of new legislation in Vietnam
-
Sponsored by Bird & BirdInformation is power in the world of FRAND licensing. Richard Vary of Bird & Bird explains how the disclosure of confidential information and trade secrets are handled in the UK
-
Sponsored by Gün and PartnersThe new system raises several questions for European Patent Convention countries that are not EU members, say Selin Sinem Erciyas, Aysel Korkmaz Yatkın, Zeynep Çağla Üstün and Aysu Eryaşar of Gün + Partners
